Trends of ciprofloxacin use in Kazakhstan, impacts of COVID-19, and strategies for AMR control
Abstract
The misuse of antibacterial agents is a key driver of the rapid and widespread rise in antimicrobial resistance (AMR). This study examines the consumption trends of ciprofloxacin-the second most consumed antibiotic in Kazakhstan across outpatient and inpatient settings-before, during, and after the COVID-19 pandemic to inform AMR mitigation strategies. The analysis is based on two data sources: a comprehensive review of national regulatory documents governing ciprofloxacin use and a pharmaco-epidemiological assessment of procurement data provided by Vi-ORTIS. Ciprofloxacin consumption (ATC group J01MA02) from 2017 to 2023 was quantified in DDD/1000 inhabitants/day (DID) via the ATC/DDD methodology. Only 16 of 50 recommendations in national protocols align with the ciprofloxacin prescribing guidelines established in international standards. During the pandemic, ciprofloxacin use increased, with total and outpatient consumption peaking in the third quarter of 2020, whereas inpatient consumption peaked earlier in the second quarter. In the post pandemic period, inpatient consumption steadily declined, reaching 0.06 DID in 2023. The persistent increase in the use of "Watch" antibiotics, including ciprofloxacin, has raised concerns for Kazakhstan's healthcare system. Strengthening antimicrobial stewardship programs, implementing targeted interventions, and enhancing surveillance efforts are essential to curbing antibiotic overuse and safeguarding public health.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.